Current protocols最新文献

筛选
英文 中文
GEDI: An R Package for Integration of Transcriptomic Data from Multiple Platforms for Bioinformatics Applications GEDI:为生物信息学应用整合来自多个平台的转录组数据的 R 软件包。
Current protocols Pub Date : 2024-10-25 DOI: 10.1002/cpz1.70046
Mathias N. Stokholm, Maria B. Rabaglino, Haja N. Kadarmideen
{"title":"GEDI: An R Package for Integration of Transcriptomic Data from Multiple Platforms for Bioinformatics Applications","authors":"Mathias N. Stokholm,&nbsp;Maria B. Rabaglino,&nbsp;Haja N. Kadarmideen","doi":"10.1002/cpz1.70046","DOIUrl":"10.1002/cpz1.70046","url":null,"abstract":"<p>Transcriptomic data is often expensive and difficult to generate in large cohorts relative to genomic data; therefore, it is often important to integrate multiple transcriptomic datasets from both microarray- and next generation sequencing (NGS)-based transcriptomic data across similar experiments or clinical trials to improve analytical power and discovery of novel transcripts and genes. However, transcriptomic data integration presents a few challenges including reannotation and batch effect removal. We developed the Gene Expression Data Integration (GEDI) R package to enable transcriptomic data integration by combining existing R packages. With just four functions, the GEDI R package makes constructing a transcriptomic data integration pipeline straightforward. Together, the functions overcome the complications in transcriptomic data integration by automatically reannotating the data and removing the batch effect. The removal of the batch effect is verified with principal component analysis and the data integration is verified using a logistic regression model with forward stepwise feature selection. To demonstrate the functionalities of the GEDI package, we integrated five bovine endometrial transcriptomic datasets from the NCBI Gene Expression Omnibus. These transcriptomic datasets were from multiple high-throughput platforms, namely, array-based Affymetrix and Agilent platforms, and NGS-based Illumina paired-end RNA-seq platform. Furthermore, we compared the GEDI package to existing tools and found that GEDI is the only tool that provides a full transcriptomic data integration pipeline including verification of both batch effect removal and data integration for downstream genomic and bioinformatics applications. © 2024 The Author(s). Current Protocols published by Wiley Periodicals LLC.</p><p><b>Basic Protocol 1</b>: ReadGE, a function to import gene expression datasets</p><p><b>Basic Protocol 2</b>: GEDI, a function to reannotate and merge gene expression datasets</p><p><b>Basic Protocol 3</b>: BatchCorrection, a function to remove batch effects from gene expression data</p><p><b>Basic Protocol 4</b>: VerifyGEDI, a function to confirm successful integration of gene expression data</p>","PeriodicalId":93970,"journal":{"name":"Current protocols","volume":"4 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cpz1.70046","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142515176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthesis of N3-Methyluridine- and 2′-O-Alkyl/2′-Fluoro-N3-Methyluridine-Modified Phosphoramidites and Their Incorporation into DNA and RNA Oligonucleotides 合成 N3-甲基尿苷和 2'-O 烷基/2'-氟-N3-甲基尿苷修饰的磷酰胺及其与 DNA 和 RNA 寡核苷酸的结合。
Current protocols Pub Date : 2024-10-25 DOI: 10.1002/cpz1.70039
Avijit Sahoo, Kiran R. Gore
{"title":"Synthesis of N3-Methyluridine- and 2′-O-Alkyl/2′-Fluoro-N3-Methyluridine-Modified Phosphoramidites and Their Incorporation into DNA and RNA Oligonucleotides","authors":"Avijit Sahoo,&nbsp;Kiran R. Gore","doi":"10.1002/cpz1.70039","DOIUrl":"10.1002/cpz1.70039","url":null,"abstract":"<p>In this article, we describe the synthesis of <i>N</i><sup>3</sup>-methyluridine (m<sup>3</sup>U) and 2′-<i>O</i>-alkyl/2′-fluoro-<i>N</i><sup>3</sup>-methyluridine (2′-<i>O</i>-alkyl/2′-F-m<sup>3</sup>U) phosphoramidites as well as their incorporation into a 14-mer DNA and RNA oligonucleotide sequence. Synthesis of the 2′-<i>O</i>-alkyl-m<sup>3</sup>U phosphoramidite starts with commercially available uridine to achieve a tritylated m<sup>3</sup>U intermediate, followed by 2′-<i>O</i>-alkylation and finally phosphitylation. Synthesis of the 2′-F-m<sup>3</sup>U phosphoramidite is obtained from a commercially available 2′-F-uridine nucleoside. These phosphoramidite monomers are compatible with DNA and RNA oligonucleotide synthesis using conventional phosphoramidite chemistry. This strategy offers efficient synthetic access to various modifications at the 2′-position of m<sup>3</sup>U that can be employed in numerous nucleic acid–based therapeutic applications, including antisense technologies, small interfering RNAs, CRISPR-Cas9, and aptamers. The data presented in this article are based on our previously published reports. © 2024 Wiley Periodicals LLC.</p><p><b>Basic Protocol 1</b>: Synthesis of 2′-<i>O</i>-alkyl-<i>N</i><sup>3</sup>-methyluridine analogs and their corresponding phosphoramidites</p><p><b>Alternate Protocol 1</b>: Synthesis of 2′-<i>O</i>-TBDMS-<i>N</i><sup>3</sup>-methyluridine and its phosphoramidite</p><p><b>Alternate Protocol 2</b>: Synthesis of 2′-fluoro-<i>N</i><sup>3</sup>-methyluridine and its phosphoramidite</p><p><b>Basic Protocol 2</b>: Solid-phase synthesis of <i>N</i><sup>3</sup>-methyluridine-modified DNA and RNA oligonucleotides</p>","PeriodicalId":93970,"journal":{"name":"Current protocols","volume":"4 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142515179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The TELCoMB Protocol for High-Sensitivity Detection of ARG-MGE Colocalizations in Complex Microbial Communities 高灵敏度检测复杂微生物群落中 ARG-MGE 共定位的 TELCoMB 方案。
Current protocols Pub Date : 2024-10-24 DOI: 10.1002/cpz1.70031
Jonathan E. Bravo, Ilya Slizovskiy, Nathalie Bonin, Marco Oliva, Noelle Noyes, Christina Boucher
{"title":"The TELCoMB Protocol for High-Sensitivity Detection of ARG-MGE Colocalizations in Complex Microbial Communities","authors":"Jonathan E. Bravo,&nbsp;Ilya Slizovskiy,&nbsp;Nathalie Bonin,&nbsp;Marco Oliva,&nbsp;Noelle Noyes,&nbsp;Christina Boucher","doi":"10.1002/cpz1.70031","DOIUrl":"10.1002/cpz1.70031","url":null,"abstract":"<p>Understanding the genetic basis of antimicrobial resistance is crucial for developing effective mitigation strategies. One necessary step is to identify the antimicrobial resistance genes (ARGs) within a microbial population, referred to as the resistome, as well as the mobile genetic elements (MGEs) harboring ARGs. Although shotgun metagenomics has been successful in detecting ARGs and MGEs within a microbiome, it is limited by low sensitivity. Enrichment using cRNA biotinylated probes has been applied to address this limitation, enhancing the detection of rare ARGs and MGEs, especially when combined with long-read sequencing. Here, we present the TELCoMB protocol, a Snakemake workflow that elucidates resistome and mobilome composition and diversity and uncovers ARG-MGE colocalizations. The protocol supports both short- and long-read sequencing and does not require enrichment, making it versatile for various genomic data types. TELCoMB generates publication-ready figures and CSV files for comprehensive analysis, improving our understanding of antimicrobial resistance mechanisms and spread. © 2024 The Author(s). Current Protocols published by Wiley Periodicals LLC.</p><p><b>Basic Protocol 1</b>: Installing TELCOMB Locally</p><p><b>Alternate Protocol</b>: Installing TELCOMB on a SLURM Cluster</p><p><b>Basic Protocol 2</b>: Data Preprocessing</p><p><b>Basic Protocol 3</b>: Calculation of Resistome Distribution and Composition</p><p><b>Basic Protocol 4</b>: Identification of ARG-MGE Colocalizations</p>","PeriodicalId":93970,"journal":{"name":"Current protocols","volume":"4 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cpz1.70031","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142515180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recording and Interpretation of Active Calcium Transients in Induced Pluripotent Stem Cell-Derived Cardiomyocytes 记录和解读诱导多能干细胞衍生心肌细胞的活性钙瞬态
Current protocols Pub Date : 2024-10-24 DOI: 10.1002/cpz1.70030
Maedeh Mozneb, Jemima Moses, Madelyn Arzt, Sean Escopete, Arun Sharma
{"title":"Recording and Interpretation of Active Calcium Transients in Induced Pluripotent Stem Cell-Derived Cardiomyocytes","authors":"Maedeh Mozneb,&nbsp;Jemima Moses,&nbsp;Madelyn Arzt,&nbsp;Sean Escopete,&nbsp;Arun Sharma","doi":"10.1002/cpz1.70030","DOIUrl":"10.1002/cpz1.70030","url":null,"abstract":"<p>Calcium plays a pivotal role in the excitation-contraction coupling process in cardiomyocytes, a critical multi-parametric event leading to rhythmic contraction. Over the past few decades, calcium signaling in cardiomyocytes has been extensively studied in cardiovascular sciences. However, a standard methodology is needed not only to trace the calcium within cells but also to remove signal processing biases and to accurately interpret the features of calcium transient signals in relation to cardiomyocyte electrophysiology. This article outlines the use of genetically encoded calcium indicator (GCaMP) human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) to record calcium transients. These cells express a green fluorescent signal when calcium binds to intracellular calmodulin, a key regulator of calcium signaling. The extraction and processing of calcium transient waveforms are performed using ImageJ and MATLAB software. Key features of these waveforms are then identified and categorized based on their physiological relevance to cardiomyocyte function. Additionally, this work includes a Support Protocol for the successful replating of cardiomyocytes onto non-traditional culture platforms, such as metallic sensors and polymer-based substrates, to facilitate data multiplexing. The three Basic Protocols outlined here provide a comprehensive approach for maintaining, expanding, and differentiating the GCaMP hiPSCs, video recording of calcium transients, and the subsequent signal extraction, preprocessing, analysis, and data visualization. © 2024 The Author(s). Current Protocols published by Wiley Periodicals LLC.</p><p><b>Basic Protocol 1</b>: Maintenance, expansion, and differentiation of genetically encoded calcium indicator hiPSCs</p><p><b>Support Protocol</b>: Replating GCaMP hiPSC-CMs for stimulation and multielectrode array studies</p><p><b>Basic Protocol 2</b>: Video recording from calcium transients of GCaMP hiPSC-CMs</p><p><b>Basic Protocol 3</b>: Signal extraction, preprocessing, analysis, and data visualization</p>","PeriodicalId":93970,"journal":{"name":"Current protocols","volume":"4 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cpz1.70030","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142515178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: Exome Sequencing Starting from Single Cells 更正:外显子组测序从单细胞开始。
Current protocols Pub Date : 2024-10-22 DOI: 10.1002/cpz1.70052
Ioanna Andreou, Markus Storbeck, Peter Hahn, Samuel Rulli, Eric Lader
{"title":"Correction: Exome Sequencing Starting from Single Cells","authors":"Ioanna Andreou,&nbsp;Markus Storbeck,&nbsp;Peter Hahn,&nbsp;Samuel Rulli,&nbsp;Eric Lader","doi":"10.1002/cpz1.70052","DOIUrl":"10.1002/cpz1.70052","url":null,"abstract":"<p><i>Current Protocols</i> is issuing corrections for the following protocol article:</p><p>Andreou, I., Storbeck, M., Hahn, P., Rulli, S., &amp; Lader, E. (2024). Exome sequencing starting from single cells. <i>Current Protocols</i>, <i>4</i>, e70017. doi: 10.1002/cpz1.70017</p><p>In the above-referenced article:</p><p>A new Table 10 has been added and the existing Table 10 has been renumbered as Table 12.</p><p>The existing Tables 12 to 14 have been renumbered as Tables 13 to 15.</p><p>The current version online now includes these corrections and may be considered the authoritative version of record.</p>","PeriodicalId":93970,"journal":{"name":"Current protocols","volume":"4 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cpz1.70052","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142515175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kindling Models of Epileptogenesis for Developing Disease-Modifying Drugs for Epilepsy 用于开发癫痫疾病治疗药物的癫痫诱发模型
Current protocols Pub Date : 2024-10-22 DOI: 10.1002/cpz1.70020
Doodipala Samba Reddy, Abhinav Vadassery, Sreevidhya Ramakrishnan, Tanveer Singh, Bryan Clossen, Xin Wu
{"title":"Kindling Models of Epileptogenesis for Developing Disease-Modifying Drugs for Epilepsy","authors":"Doodipala Samba Reddy,&nbsp;Abhinav Vadassery,&nbsp;Sreevidhya Ramakrishnan,&nbsp;Tanveer Singh,&nbsp;Bryan Clossen,&nbsp;Xin Wu","doi":"10.1002/cpz1.70020","DOIUrl":"10.1002/cpz1.70020","url":null,"abstract":"<p>Kindling models are widely used animal models to study the pathobiology of epilepsy and epileptogenesis. These models exhibit distinctive features whereby sub-threshold stimuli instigate the initial induction of brief focal seizures. Over time, the severity and duration of these seizures progressively increase, leading to a fully epileptic state, which is marked by consistent development of generalized tonic-clonic seizures. Kindling involves focal stimulation via implanted depth electrodes or repeated administration of chemoconvulsants such as pentylenetetrazol. Comparative analysis of preclinical and clinical findings has confirmed a high predictive validity of fully kindled animals for testing novel antiseizure medications. Thus, kindling models remain an essential component of anticonvulsant drug development programs. This article provides a comprehensive guide to working protocols, testing of therapeutic drugs, outcome parameters, troubleshooting, and data analysis for various electrical and chemical kindling epileptogenesis models for new therapeutic development and optimization. The use of pharmacological agents or genetically modified mice in kindling experiments is valuable, offering insights into the impact of a specific target on various aspects of seizures, including thresholds, initiation, spread, termination, and the generation of a hyperexcitable network. These kindling epileptogenesis paradigms are helpful in identifying mechanisms and disease-modifying interventions for epilepsy. © 2024 The Author(s). Current Protocols published by Wiley Periodicals LLC.</p><p><b>Basic Protocol 1</b>: Hippocampal kindling</p><p><b>Basic Protocol 2</b>: Amygdala kindling</p><p><b>Basic Protocol 3</b>: Rapid hippocampal kindling</p><p><b>Basic Protocol 4</b>: Chemical kindling</p>","PeriodicalId":93970,"journal":{"name":"Current protocols","volume":"4 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11498896/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142483996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Working with Miraculous Mice: Mus musculus as a Model Organism 与神奇的小鼠共事:作为模式生物的麝。
Current protocols Pub Date : 2024-10-22 DOI: 10.1002/cpz1.70021
Anick Standley, Jinhan Xie, Angelica WY Lau, Lauren Grote, Andrew J. Gifford
{"title":"Working with Miraculous Mice: Mus musculus as a Model Organism","authors":"Anick Standley,&nbsp;Jinhan Xie,&nbsp;Angelica WY Lau,&nbsp;Lauren Grote,&nbsp;Andrew J. Gifford","doi":"10.1002/cpz1.70021","DOIUrl":"10.1002/cpz1.70021","url":null,"abstract":"<p>The laboratory mouse has been described as a “miracle” model organism, providing a window by which we may gain an understanding of ourselves. Since the first recorded mouse experiment in 1664, the mouse has become the most used animal model in biomedical research. Mice are ideally suited as a model organism because of their small size, short gestation period, large litter size, and genetic similarity to humans. This article provides a broad overview of the laboratory mouse as a model organism and is intended for undergraduates and those new to working with mice. We delve into the history of the laboratory mouse and outline important terminology to accurately describe research mice. The types of laboratory mice available to researchers are reviewed, including outbred stocks, inbred strains, immunocompromised mice, and genetically engineered mice. The critical role mice have played in advancing knowledge in the areas of oncology, immunology, and pharmacology is highlighted by examining the significant contribution of mice to Nobel Prize winning research. International mouse mutagenesis programs and accurate phenotyping of mouse models are outlined. We also explain important considerations for working with mice, including animal ethics; the welfare principles of replacement, refinement, and reduction; and the choice of mouse model in experimental design. Finally, we present practical advice for maintaining a mouse colony, which involves adequate training of staff, the logistics of mouse housing, monitoring colony health, and breeding strategies. Useful resources for working with mice are also listed. The aim of this overview is to equip the reader with a broad appreciation of the enormous potential and some of the complexities of working with the laboratory mouse in a quest to improve human health. © 2024 The Author(s). Current Protocols published by Wiley Periodicals LLC.</p>","PeriodicalId":93970,"journal":{"name":"Current protocols","volume":"4 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cpz1.70021","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142483998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Generation of Murine Cancer Cell Lines 生成小鼠癌症细胞系。
Current protocols Pub Date : 2024-10-21 DOI: 10.1002/cpz1.70037
Cheryl Zhang, Anthony Lin, Xiang Chen, Yi-Chieh Nancy Du
{"title":"Generation of Murine Cancer Cell Lines","authors":"Cheryl Zhang,&nbsp;Anthony Lin,&nbsp;Xiang Chen,&nbsp;Yi-Chieh Nancy Du","doi":"10.1002/cpz1.70037","DOIUrl":"10.1002/cpz1.70037","url":null,"abstract":"<p>Cancer cell lines are important tools to investigate the biology of cancer and test hypotheses to improve cancer treatments. A major challenge in establishing epithelial cancer cell lines is the removal of cancer-associated fibroblasts (CAFs). CAFs are abundant within the tumor microenvironment. CAFs generally proliferate faster than epithelial cancer cells in culture. CAFs can be mistakenly identified as cancer cells, especially when cancer cells display spindle-shaped morphology. Among all cancer types, pancreatic ductal adenocarcinoma (PDAC) is characterized by an abundant desmoplastic stroma. Here, we describe protocols for establishing epithelial cancer cell lines from mouse models of PDAC and verifying that they are not CAFs. The approach is cost-effective and can be used for other types of cancer. If needed, CAF cell lines can also be established and preserved using this protocol. © 2024 Wiley Periodicals LLC.</p><p><b>Basic Protocol 1</b>: Isolation of cells from tumors</p><p><b>Basic Protocol 2</b>: Isolation and cryopreservation of cancer cell clones</p><p><b>Basic Protocol 3</b>: Assessment of the identity of cancer cell lines and CAFs by western blotting</p>","PeriodicalId":93970,"journal":{"name":"Current protocols","volume":"4 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142483995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Using Spectral Flow Cytometry to Characterize Anti-Tumor Immunity in Orthotopic and Subcutaneous Mouse Models of Cancer 利用光谱流式细胞术鉴定正位和皮下小鼠癌症模型的抗肿瘤免疫特性
Current protocols Pub Date : 2024-10-21 DOI: 10.1002/cpz1.70032
Giampiero Valenzano, Shannon N. Russell, Simei Go, Eric O'Neill, Keaton I. Jones
{"title":"Using Spectral Flow Cytometry to Characterize Anti-Tumor Immunity in Orthotopic and Subcutaneous Mouse Models of Cancer","authors":"Giampiero Valenzano,&nbsp;Shannon N. Russell,&nbsp;Simei Go,&nbsp;Eric O'Neill,&nbsp;Keaton I. Jones","doi":"10.1002/cpz1.70032","DOIUrl":"10.1002/cpz1.70032","url":null,"abstract":"<p>Mouse models remain at the forefront of immuno-oncology research, providing invaluable insights into the complex interactions between the immune system and developing tumors. While several flow cytometry panels have been developed to study cancer immunity in mice, most are limited in their capacity to address the complexity of anti-cancer immune responses. For example, many of the panels developed to date focus on a restricted number of leukocyte populations (T cells or antigen-presenting cells), failing to include the multitude of other subsets that participate in anti-cancer immunity. In addition, these panels were developed using blood or splenic leukocytes. While the immune composition of the blood or spleen can provide information on systemic immune responses to cancer, it is in the tumor microenvironment (TME) that local immunity takes place. Therefore, we optimized this spectral flow cytometry panel to identify the chief cell types that take part in cancer immunity using immune cells from cancer tissue. We used pancreatic tumors implanted both orthotopically and subcutaneously to demonstrate the panel's flexibility and suitability in diverse mouse models. The panel was also validated in peripheral immune districts (the blood, spleen, and liver of tumor-bearing mice) to allow comparisons between local and systemic anti-tumor immunity. © 2024 The Author(s). Current Protocols published by Wiley Periodicals LLC.</p><p><b>Basic Protocol 1</b>: Tumor induction—Orthotopic</p><p><b>Alternate Protocol</b>: Tumor induction—Subcutaneous</p><p><b>Basic Protocol 2</b>: Preparation of single-cell suspensions from the tumor, spleen, liver, and blood of tumor-bearing mice</p><p><b>Basic Protocol 3</b>: Staining single-cell suspensions from the tumor, spleen, liver, and blood of tumor-bearing mice</p>","PeriodicalId":93970,"journal":{"name":"Current protocols","volume":"4 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cpz1.70032","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142483997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
De Novo Synthesis of Error-Free Long Oligos 从头合成无差错长寡糖
Current protocols Pub Date : 2024-10-18 DOI: 10.1002/cpz1.70028
Shiyue Fang, Reed Arneson, Yipeng Yin, Yinan Yuan
{"title":"De Novo Synthesis of Error-Free Long Oligos","authors":"Shiyue Fang,&nbsp;Reed Arneson,&nbsp;Yipeng Yin,&nbsp;Yinan Yuan","doi":"10.1002/cpz1.70028","DOIUrl":"https://doi.org/10.1002/cpz1.70028","url":null,"abstract":"<p>This protocol describes the synthesis of long oligonucleotides (up to 401-mer), their isolation from complex mixtures using the catching-by-polymerization (CBP) method, and the selection of error-free sequence via cloning followed by Sanger sequencing. Oligo synthesis is achieved under standard automated solid-phase synthesis conditions with only minor yet critical adjustments using readily available reagents. The CBP method involves tagging the full-length sequence with a polymerizable tagging phosphoramidite (PTP), co-polymerizing the sequence into a polymer, washing away failure sequences, and cleaving the full-length sequence from the polymer. Cloning and sequencing guided selection of error-free sequence overcome the problems of substitution, deletion, and addition errors that cannot be addressed using any other methods, including CBP. Long oligos are needed in many areas such as protein engineering and synthetic biology. The methods described here are particularly important for projects requiring long oligos containing long repeats or stable higher-order structures, which are difficult or impossible to produce using any other existing technologies. © 2024 Wiley Periodicals LLC.</p><p><b>Basic Protocol 1</b>: Long oligo synthesis</p><p><b>Support Protocol 1</b>: Synthesis of polymerizable tagging phosphoramidite (PTP)</p><p><b>Support Protocol 2</b>: Synthesis of 5′-<i>O</i>-Bz phosphoramidite</p><p><b>Basic Protocol 2</b>: Catching-by-polymerization (CBP) purification</p><p><b>Basic Protocol 3</b>: Error-free sequence selection via cloning and sequencing</p>","PeriodicalId":93970,"journal":{"name":"Current protocols","volume":"4 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142451242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信